Further to admission to trading today of the new Ordinary Shares ("Ordinary Shares") that were issued in connection with the recent subscription and PrimaryBid Offer (the "Fundraising"), Executive Chairman Robert Price's holding now represents 8.79% of the Company's total voting rights. The number of Ordinary Shares held by Mr Price has not changed.
Highlands Natural Resources plc
+1 (0) 303 322 1066
Cantor Fitzgerald Europe
+44 (0) 20 7894 7000
+44 (0) 20 3757 6880
Notes to Editors
Highlands (LSE: HNR.L) is a London-listed natural resources company with a portfolio of high-potential assets and technologies. The Company's core projects include:
· Colorado Shale: Highlands holds a 7.5% carried interest in the East Denver Niobrara shale project. East Denver is currently producing from eight wells, with the potential for up to 24 wells in total. At its West Denver project, Highlands holds c. 5,300-acres of leases geologically similar to the East Denver project. This division also includes its patented anti well-bashing technology, DT Ultravert, successfully deployed in the Permian in 2018 and Piceance basins in 2016.
· Kansas Gas Resource: 3,457-acres with the first well producing hydrogen-nitrogen with an initial flow rate of 2,581 Mcfpd. Potential for an additional 24 wells.
· Highlands Water Resources: formed to facilitate a range of initiatives focused on easing the water shortage currently being experienced across the US oil and gas industry, and particularly across more arid States such as Colorado. Utilises the E10X modular solar powered water-recycling units. Highlands is also exploring the potential to supply water from its 154,072 acreage in Montana.
· Zoetic Organics: newly formed subsidiary targeting the production of premium organic CBD products into wholesale and retail channels from a 33,000 sq. ft. indoor facility (potential annual harvest of 40,000 hemp plants) and an initial 20-acre outdoor growing facility (potential annual harvest of 50,000 hemp plants).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...